{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T18:41:17Z","timestamp":1789065677052,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2021-NF000572"],"award-info":[{"award-number":["RS-2021-NF000572"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00260454"],"award-info":[{"award-number":["RS-2023-00260454"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00336114"],"award-info":[{"award-number":["RS-2024-00336114"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-02216523"],"award-info":[{"award-number":["RS-2025-02216523"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-19032970"],"award-info":[{"award-number":["RS-2025-19032970"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-25426460"],"award-info":[{"award-number":["RS-2025-25426460"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by aberrant germinal center (GC) reactions and autoantibody production. Expansion of T follicular helper (T\n                    <jats:sub>FH<\/jats:sub>\n                    ) cells is a hallmark of SLE that contributes to disease progression. Accordingly, T\n                    <jats:sub>FH<\/jats:sub>\n                    cells represent a promising therapeutic target for SLE. Here, we repurposed obeticholic acid (OCA), an FDA-approved drug for primary biliary cholangitis, as a potential treatment for SLE. OCA selectively inhibited the differentiation of T\n                    <jats:sub>FH<\/jats:sub>\n                    cells both in vitro and in vivo by suppressing the transcription factor ETV5, thereby downregulating\n                    <jats:italic>SPP1<\/jats:italic>\n                    , a key ETV5 target that promotes the development of T\n                    <jats:sub>FH<\/jats:sub>\n                    cells. In lupus-prone mice, OCA treatment reduced T\n                    <jats:sub>FH<\/jats:sub>\n                    - and GC B-cell populations and alleviated lupus-like manifestations, including autoantibody production and tissue pathology. These findings highlight OCA as a promising immunomodulatory candidate for SLE, providing avenues for devising a therapeutic strategy targeting the T\n                    <jats:sub>FH<\/jats:sub>\n                    cell\u2013GC axis in systemic autoimmunity.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00478-6","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:03:31Z","timestamp":1783091011000},"page":"3258-3277","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Obeticholic acid alleviates lupus pathology by inhibiting T follicular helper cell differentiation"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7945-124X","authenticated-orcid":false,"given":"Minjung","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7612-1577","authenticated-orcid":false,"given":"Jiho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-2329","authenticated-orcid":false,"given":"Jongeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Won Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-3087","authenticated-orcid":false,"given":"Yoontae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"478_CR1","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1080\/14656566.2016.1218471","volume":"17","author":"AH Ali","year":"2016","unstructured":"Ali AH, Lindor KD (2016) Obeticholic acid for the treatment of primary biliary cholangitis. Expert Opin Pharmacother 17:1809\u20131815","journal-title":"Expert Opin Pharmacother"},{"key":"478_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12629-4","volume":"7","author":"YM Attia","year":"2017","unstructured":"Attia YM, Tawfiq RA, Ali AA, Elmazar MM (2017) The FXR agonist, obeticholic acid, suppresses HCC proliferation & metastasis: role of IL-6\/STAT3 signalling pathway. Sci Rep 7:12502","journal-title":"Sci Rep"},{"key":"478_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","volume":"76","author":"MJ Barnden","year":"1998","unstructured":"Barnden MJ, Allison J, Heath WR, Carbone FR (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34\u201340","journal-title":"Immunol Cell Biol"},{"key":"478_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/eji.201545760","volume":"46","author":"P Blanco","year":"2016","unstructured":"Blanco P, Ueno H, Schmitt N (2016) T follicular helper (Tfh) cells in lupus: activation and involvement in SLE pathogenesis. Eur J Immunol 46:281\u2013290","journal-title":"Eur J Immunol"},{"key":"478_CR5","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.mocell.2024.100141","volume":"47","author":"D Bong","year":"2024","unstructured":"Bong D, Sohn J, Lee SV (2024) Brief guide to RT-qPCR. Mol Cells 47:100141","journal-title":"Mol Cells"},{"key":"478_CR6","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4110\/in.2024.24.e8","volume":"24","author":"J Choi","year":"2024","unstructured":"Choi J, Crotty S, Choi YS (2024) Cytokines in follicular helper T cell biology in physiologic and pathologic conditions. Immune Netw 24:e8","journal-title":"Immune Netw"},{"key":"478_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/life15040666","volume":"15","author":"M Christodoulou","year":"2025","unstructured":"Christodoulou M, Moysidou E, Lioulios G, Stai S, Lazarou C, Xochelli A, Fylaktou A, Stangou M (2025) T-follicular helper cells and their role in autoimmune diseases. Life 15:666","journal-title":"Life"},{"key":"478_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrrheum.2012.58","volume":"8","author":"JE Craft","year":"2012","unstructured":"Craft JE (2012) Follicular helper T cells in immunity and systemic autoimmunity. Nat Rev Rheumatol 8:337\u2013347","journal-title":"Nat Rev Rheumatol"},{"key":"478_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty S (2014) T follicular helper cell differentiation, function, and roles in disease. Immunity 41:529\u2013542","journal-title":"Immunity"},{"key":"478_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A et al (2024) EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis 83:15\u201329","journal-title":"Ann Rheum Dis"},{"key":"478_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen EC, Renooij W, Murzilli S, Klomp LW, Siersema PD, Schipper ME, Danese S et al (2011) Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60:463\u2013472","journal-title":"Gut"},{"key":"478_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41423-019-0329-7","volume":"17","author":"X Gao","year":"2020","unstructured":"Gao X, Wang H, Chen Z, Zhou P, Yu D (2020) An optimized method to differentiate mouse follicular helper T cells in vitro. Cell Mol Immunol 17:779\u2013781","journal-title":"Cell Mol Immunol"},{"key":"478_CR13","doi-asserted-by":"publisher","first-page":"i22","DOI":"10.1093\/rheumatology\/keac678","volume":"62","author":"J He","year":"2023","unstructured":"He J, Li Z (2023) Dilemma of immunosuppression and infection risk in systemic lupus erythematosus. Rheumatology 62:i22\u2013i29","journal-title":"Rheumatology"},{"key":"478_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","volume":"20","author":"MJ Henley","year":"2021","unstructured":"Henley MJ, Koehler AN (2021) Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules. Nat Rev Drug Discov 20:669\u2013688","journal-title":"Nat Rev Drug Discov"},{"key":"478_CR15","doi-asserted-by":"publisher","first-page":"110386","DOI":"10.1016\/j.celrep.2022.110386","volume":"38","author":"H Hong","year":"2022","unstructured":"Hong H, Lee J, Park GY, Kim S, Park J, Park JS, Song Y, Lee S, Kim TJ, Lee YJ et al (2022) Postnatal regulation of B-1a cell development and survival by the CIC-PER2-BHLHE41 axis. Cell Rep 38:110386","journal-title":"Cell Rep"},{"key":"478_CR16","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00296-023-05306-5","volume":"43","author":"PB Katarzyna","year":"2023","unstructured":"Katarzyna PB, Wiktor S, Ewa D, Piotr L (2023) Current treatment of systemic lupus erythematosus: a clinician\u2019s perspective. Rheumatol Int 43:1395\u20131407","journal-title":"Rheumatol Int"},{"key":"478_CR17","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G (2016) Systemic lupus erythematosus. Nat Rev Dis Prim 2:16039","journal-title":"Nat Rev Dis Prim"},{"key":"478_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.immuni.2018.10.012","volume":"49","author":"CJ Kim","year":"2018","unstructured":"Kim CJ, Lee CG, Jung JY, Ghosh A, Hasan SN, Hwang SM, Kang H, Lee C, Kim GC, Rudra D et al (2018) The transcription factor Ets1 suppresses T follicular helper type 2 cell differentiation to halt the onset of systemic lupus erythematosus. Immunity 49:1034\u20131048e1038","journal-title":"Immunity"},{"key":"478_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.5483\/BMBRep.2024-0027","volume":"58","author":"H Kim","year":"2025","unstructured":"Kim H, Jang S, Lee SY, Kwon JH, Byun S, Yoo JY, Yu S, Park SY, Yoon HG (2025) JMJD4 promotes tumor progression via inhibition of the PDCD5-TP53 pathway. BMB Rep 58:64\u201369","journal-title":"BMB Rep"},{"key":"478_CR20","doi-asserted-by":"publisher","first-page":"e2420313122","DOI":"10.1073\/pnas.2420313122","volume":"122","author":"J Lee","year":"2025","unstructured":"Lee J, Park J, Hur Y, Um D, Choi HS, Park J, Kim Y, Lee JS, Choi K, Kim E et al (2025) ETV5 reduces androgen receptor expression and induces neural stem-like properties during neuroendocrine prostate cancer development. Proc Natl Acad Sci USA 122:e2420313122","journal-title":"Proc Natl Acad Sci USA"},{"key":"478_CR21","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","volume":"15","author":"PP Lee","year":"2001","unstructured":"Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Perez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S et al (2001) A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15:763\u2013774","journal-title":"Immunity"},{"key":"478_CR22","doi-asserted-by":"publisher","first-page":"14549","DOI":"10.1111\/jcmm.16083","volume":"24","author":"S Li","year":"2020","unstructured":"Li S, Xu Z, Guo J, Zheng J, Sun X, Yu J (2020) Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2\/STAT3 signalling via transactivation of SOCS3 gene. J Cell Mol Med 24:14549\u201314560","journal-title":"J Cell Mol Med"},{"key":"478_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/ni.3494","volume":"17","author":"M Locci","year":"2016","unstructured":"Locci M, Wu JE, Arumemi F, Mikulski Z, Dahlberg C, Miller AT, Crotty S (2016) Activin A programs the differentiation of human TFH cells. Nat Immunol 17:976\u2013984","journal-title":"Nat Immunol"},{"key":"478_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ng.3808","volume":"49","author":"HC Lu","year":"2017","unstructured":"Lu HC, Tan Q, Rousseaux MW, Wang W, Kim JY, Richman R, Wan YW, Yeh SY, Patel JM, Liu X et al (2017) Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans. Nat Genet 49:527\u2013536","journal-title":"Nat Genet"},{"key":"478_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.molmed.2025.06.003","volume":"32","author":"EF Morand","year":"2026","unstructured":"Morand EF, Jones SA (2026) 10 years in lupus\u2014progress, but not enough. Trends Mol Med 32:11\u201318","journal-title":"Trends Mol Med"},{"key":"478_CR26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N et al (2011) Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108\u2013121","journal-title":"Immunity"},{"key":"478_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/1744666X.2021.1976146","volume":"17","author":"S Nakayamada","year":"2021","unstructured":"Nakayamada S, Tanaka Y (2021) Clinical relevance of T follicular helper cells in systemic lupus erythematosus. Expert Rev Clin Immunol 17:1143\u20131150","journal-title":"Expert Rev Clin Immunol"},{"key":"478_CR28","doi-asserted-by":"publisher","first-page":"e2322009121","DOI":"10.1073\/pnas.2322009121","volume":"121","author":"J Park","year":"2024","unstructured":"Park J, Lee J, Hur Y, Kim CJ, Kim HB, Um D, Kim DS, Lee JY, Park S, Park Y et al (2024) ETV5 promotes lupus pathogenesis and follicular helper T cell differentiation by inducing osteopontin expression. Proc Natl Acad Sci USA 121:e2322009121","journal-title":"Proc Natl Acad Sci USA"},{"key":"478_CR29","doi-asserted-by":"publisher","first-page":"100277","DOI":"10.1016\/j.mocell.2025.100277","volume":"48","author":"JS Park","year":"2025","unstructured":"Park JS, Lee Y (2025) Immune cell isolation from lymphoid and nonlymphoid organs. Mol Cells 48:100277","journal-title":"Mol Cells"},{"key":"478_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16037","volume":"8","author":"S Park","year":"2017","unstructured":"Park S, Lee S, Lee CG, Park GY, Hong H, Lee JS, Kim YM, Lee SB, Hwang D, Choi YS et al (2017) Capicua deficiency induces autoimmunity and promotes follicular helper T cell differentiation via derepression of ETV5. Nat Commun 8:16037","journal-title":"Nat Commun"},{"key":"478_CR31","first-page":"316","volume":"44","author":"R Popa","year":"2018","unstructured":"Popa R, Lautaru LA, Lucretiu R, Ruiu DC, Caragea D, Olteanu M, Mihailovici AR, Ene C, Padureanu V, Padureanu R et al (2018) Therapy side effects in systemic lupus erythematosus. Curr Health Sci J 44:316\u2013321","journal-title":"Curr Health Sci J"},{"key":"478_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","volume":"30","author":"WH Reeves","year":"2009","unstructured":"Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L (2009) Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 30:455\u2013464","journal-title":"Trends Immunol"},{"key":"478_CR33","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/ar4150","volume":"15","author":"OJ Rullo","year":"2013","unstructured":"Rullo OJ, Woo JM, Parsa MF, Hoftman AD, Maranian P, Elashoff DA, Niewold TB, Grossman JM, Hahn BH, McMahon M et al (2013) Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther 15:R18","journal-title":"Arthritis Res Ther"},{"key":"478_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/art.25032","volume":"62","author":"N Simpson","year":"2010","unstructured":"Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, Manku H, Vyse TJ, Roncador G, Huttley GA et al (2010) Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 62:234\u2013244","journal-title":"Arthritis Rheum"},{"key":"478_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5483\/BMBRep.2024-0175","volume":"58","author":"MJ Song","year":"2025","unstructured":"Song MJ, Kim M, Seo J, Kwon HW, Yang CH, Joo JS, Cho YJ, Kim HP (2025) Role of histone modification in chromatin-mediated transcriptional repression in protozoan parasite Trichomonas vaginalis. BMB Rep 58:82\u201388","journal-title":"BMB Rep"},{"key":"478_CR36","doi-asserted-by":"publisher","first-page":"100129","DOI":"10.1016\/j.mocell.2024.100129","volume":"47","author":"Y Song","year":"2024","unstructured":"Song Y, Lee Y (2024) Brief guide to flow cytometry. Mol Cells 47:100129","journal-title":"Mol Cells"},{"key":"478_CR37","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110\u20132121","journal-title":"N Engl J Med"},{"key":"478_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature03555","volume":"435","author":"CG Vinuesa","year":"2005","unstructured":"Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T et al (2005) A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435:452\u2013458","journal-title":"Nature"},{"key":"478_CR39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/nri2637","volume":"9","author":"CG Vinuesa","year":"2009","unstructured":"Vinuesa CG, Sanz I, Cook MC (2009) Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 9:845\u2013857","journal-title":"Nat Rev Immunol"},{"key":"478_CR40","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41423-025-01309-3","volume":"22","author":"X Wang","year":"2025","unstructured":"Wang X, Ye L, Liu S, Zheng Y, Zhu L, Huang W, Song J, Shao J, Wu F, Zhang C et al (2025) FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus. Cell Mol Immunol 22:889\u2013900","journal-title":"Cell Mol Immunol"},{"key":"478_CR41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","volume":"44","author":"CK Wong","year":"2005","unstructured":"Wong CK, Lit LC, Tam LS, Li EK, Lam CW (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology 44:602\u2013606","journal-title":"Rheumatology"},{"key":"478_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10787-022-00932-0","volume":"30","author":"C Xu","year":"2022","unstructured":"Xu C, Wu Y, Liu N (2022) Osteopontin in autoimmune disorders: current knowledge and future perspective. Inflammopharmacology 30:385\u2013396","journal-title":"Inflammopharmacology"},{"key":"478_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.devcel.2009.02.008","volume":"16","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Verheyden JM, Hassell JA, Sun X (2009) FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. Dev Cell 16:607\u2013613","journal-title":"Dev Cell"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00478-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00478-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00478-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:31:58Z","timestamp":1786516318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00478-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00478-6","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MK, JP, and YL have a patent application related to OCA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}